Author: Paula McGrath

New developments in the search for treatments for Stargardt disease

January 31, 2019

Researchers funded by Retina UK have contributed to the early development of potential new treatments for Stargardt disease, with their findings recently published in the journal Genetics in Medicine. Stargardt …

“First-in-class” treatment for vision loss in Usher syndrome takes a step towards clinical testing

December 6, 2018

A potentially transformative new treatment for vision loss in Usher syndrome type 2 has been given the go-ahead for initial clinical testing in a small number of adults living with …

Retina UK Ambassasor wins Venus Award for Inspirational Woman of the Year

Award winning business woman, entrepreneur and Retina UK ambassador Seema Flower recently won the award for the London 2018 Venus Award Inspirational Woman of the Year. At a ceremony that …

Gene therapy for RPE65 gene approved for use in EU

November 23, 2018

The gene therapy Luxturna has won European regulatory approval for the treatment of inherited retinal dystrophy caused by mutations in the RPE65 gene. This milestone decision was made by the …

Ophthalmology clinical research activity on the increase in the UK

November 22, 2018

Ophthalmology research in the NHS has grown and become more accessible to patients over the last eight years, according to a newly published report in the journal Eye. This is …